Welcome to the international HTA database
Showing [3319 Records] Selected Records [0 Hits] [Clear]
| Year | Source | Title | |
|---|---|---|---|
| 2003 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Rasburicase and hyperuricemia in cancer patients | |
| 2003 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Semi-implantable, middle ear hearing aids | |
| 2003 | WorkSafeBC | Cryocuffs | |
| 2003 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Treating osteoporosis with teriparatide: many unknowns? | |
| 2003 | WorkSafeBC | Detecting malingerers: hidden truths? A systematic literature review on the use of Positron Emission Tomography (PET) and 'malingering' | |
| 2003 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Treatments for benign prostatic hypertrophy | |
| 2003 | WorkSafeBC | Extra corporeal shockwave therapy (Sonocur) in workers with lateral epicondylitis | |
| 2003 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Voriconazole | |
| 2003 | Canadian Task Force on Preventive Health Care (CTFPHC) | Screening for lung cancer: updated recommendations from the Canadian Task Force on Preventive Health Care | |
| 2003 | WorkSafeBC | Homoeopathic practices: review of published systematic reviews | |
| 2003 | Canadian Task Force on Preventive Health Care (CTFPHC) | The role of vitamin E supplements in the prevention of cardiovascular disease and cancer: systematic review and recommendations | |
| 2003 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Auto-titrating nasal continuous positive airway pressure systems in the management of obstructive sleep apnea | |
| 2003 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Gastro-duodenal ulcers associated with the use of non-steroidal anti-inflammatory drugs: a systematic review of preventive pharmacological interventions | |
| 2003 | Medical Advisory Secretariat (MAS) | Scintimammography | |
| 2003 | Medical Advisory Secretariat (MAS) | Enhanced external counterpulsation (EECP) | |
| 2003 | Technology Assessment Unit of the McGill University Health Centre (MUHC) | Use of the implantable cardiac defibrillator (ICD) at the McGill University Health Centre (MUHC) | |
| 2003 | Medical Advisory Secretariat (MAS) | Small bowel transplant: an evidence-based analysis | |
| 2003 | Technology Assessment Unit of the McGill University Health Centre (MUHC) | The use of self-expanding metallic stents in the palliation of dysphagia in patients with malignant esophageal strictures | |
| 2003 | Medical Advisory Secretariat (MAS) | Wireless capsule endoscopy: an evidence-based analysis | |
| 2003 | Technology Assessment Unit of the McGill University Health Centre (MUHC) | An evaluation of drug eluting (coated) stents for percutaneous coronary interventions: what should their role be at the McGill University Health Centre (MUHC)? | |
| 2003 | Medical Advisory Secretariat (MAS) | Neonatal screening of inborn errors of metabolism using tandem mass spectrometer: an evidence-based analysis | |
| 2003 | Medical Advisory Secretariat (MAS) | Implantable cardioverter defibrillator - prophylactic use | |
| 2003 | Medical Advisory Secretariat (MAS) | Islet transplantation: an evidence-based analysis | |
| 2003 | Medical Advisory Secretariat (MAS) | Computed tomographic colonography: an evidence-based analysis | |
| 2003 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Wireless capsule endoscopy | |
| 2003 | Medical Advisory Secretariat (MAS) | Functional cardiac magnetic resonance imaging in the assessment of myocardial viability and perfusion | |
| 2003 | Medical Advisory Secretariat (MAS) | Patient monitoring system for MRI: an evidence-based analysis | |
| 2003 | Canadian Task Force on Preventive Health Care (CTFPHC) | Interventions to promote breastfeeding: updated recommendations from the Canadian Task Force on Preventive Health Care | |
| 2003 | Canadian Task Force on Preventive Health Care (CTFPHC) | Postmenopausal hormone replacement therapy for the primary prevention of cardiovascular and cerebrovascular disease: systematic review and recommendations | |
| 2003 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | [Evaluation of techniques for detecting breast implant rupture] | |
| 2003 | Canadian Task Force on Preventive Health Care (CTFPHC) | Prevention of falls in long-term care facilities: systematic review and recommendations | |
| 2003 | WorkSafeBC | Acupuncture: summary of published systematic reviews | |
| 2003 | Alberta Heritage Foundation for Medical Research (AHFMR) | Decision-making for health care systems: a legal perspective | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Hand-carried ultrasound units for point-of-care cardiac examinations | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Agalsidase alpha and agalsidase beta | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Bosentan | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Imatinib mesylate for chronic myeloid leukemia: what do we really know? | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Etonogestrel/ethinyl estradiol | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Photodynamic therapy with verteporfin for the treatment of neovascular age-related macular degeneration: a clinical assessment | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Insulin aspart | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | The role of clopidogrel in the secondary prevention of recurrent ischemic vascular events after acute myocardial ischemia: a critical appraisal of the CURE trial. | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Levetiracetam | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Endovascular repair compared with open surgical repair of abdominal aortic aneurysm: Canadian practice and a systematic review | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | The efficacy of proton pump inhibitors in adults with functional dyspepsia | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Tiotropium: a potential replacement for ipratropium in patients with COPD | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Brachytherapy for prostate cancer | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Early newborn discharge | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Relative benefits of various types of hip prostheses | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Sacral nerve stimulation device for urinary incontinence | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Tension-free vaginal tape (TVT) for urinary incontinence | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Endoscopic suturing system | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Efficacy and/or effectiveness of spirometry and forced oscillation technique in the diagnosis of childhood asthma | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | MammoSite radiation therapy system | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Metal-on-metal hip resurfacing for young, active adults with degenerative hip disease | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Radio frequency energy | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Cryosurgery for prostate cancer | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Intracoronary brachytherapy for the treatment of in-stent restenosis | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Osteogenic protein-1 for fracture healing | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Treatment of thoracic insufficiency syndrome with the vertical expandable prosthetic titanium rib | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Trigger point injections for non-malignant chronic pain | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Uterine artery embolization for the treatment of fibroids | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Fondaparinux for post-operative venous thrombosis prophylaxis | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Long-acting beta2-agonists for maintenance therapy of stable chronic obstructive pulmonary disease: a systematic review | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Heart failure: is there a role for angiotensin II receptor blockers? | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Prevalence of chronic pain: an overview | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Scleral support surgery for pathologic myopia | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Treatment of inoperable advanced non-small-cell lung cancer: regimens with or without taxane | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Drug eluting stents: managing coronary artery stenosis following PTCA | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | AHFMR screening procedure for use when considering the implementation of health technology | |
| 2002 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | Endometrial ablation techniques in the treatment of dysfunctional uterine bleeding | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Efficacy of rosiglitazone and pioglitazone compared to other anti-diabetic agents: systematic review and budget impact analysis | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Digital mammography versus film-screen mammography: technical, clinical and economic assessments | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Local health technology assessment: a guide for health authorities | |
| 2002 | Technology Assessment Unit of the McGill University Health Centre (MUHC) | Should the McGill University Health Center replace the Jelco/Cathlon catheter by the ProtectIVPlus catheter for intravenous infusions? | |
| 2002 | Technology Assessment Unit of the McGill University Health Centre (MUHC) | Should the McGill University Health Centre initiate an antiviral treatment programme for patients with chronic hepatitis C? | |
| 2002 | Technology Assessment Unit of the McGill University Health Centre (MUHC) | Should the McGill University Health Center use mitoxantrone in the treatment of multiple sclerosis? | |
| 2002 | Technology Assessment Unit of the McGill University Health Centre (MUHC) | An evaluation of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions at the MUHC: is there a difference between the drugs? | |
| 2002 | Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) | Gamma knife and linear accelerator stereotactic radiosurgery | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | The Pediatric Economic Database Evaluation (PEDE) project | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Tiotropium bromide | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Ertapenem | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Etoricoxib | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Aripiprazole | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Darbepoetin alpha | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Glimepiride | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Treprostinil | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Tegaserod hydrogen maleate | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Valdecoxib | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Economic evaluation of population-based screening for colorectal cancer | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Breath test for the detection of impaired glucose tolerance | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Transmyocardial revascularization for treatment of angina | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Topical ozone therapy for the treatment of diabetic leg ulcers | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Virtual colonoscopy (computed tomography colonography) | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Efficacy of suicide prevention programs for children and youth | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Atomoxetine | |
| 2002 | Alberta Heritage Foundation for Medical Research (AHFMR) | Accuracy and reliability of using computerized interpretation of electrocardiograms for routine examinations | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Percutaneous vertebroplasty: a bone cement procedure for spinal pain relief | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Continuous glucose monitoring in the management of diabetes mellitus | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | The cost-effectiveness of celecoxib and rofecoxib in patients with osteoarthritis or rheumatoid arthritis | |
| 2002 | Canadian Coordinating Office for Health Technology Assessment (CCOHTA) | Economic assessment: celecoxib and rofecoxib for patients with osteoarthritis or rheumatoid arthritis |